• Something wrong with this record ?

Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

E. Cavalier, T. Zima, P. Datta, K. Makris, E. Schaeffner, M. Langlois, M. Plebani, P. Delanaye, EFLM Task Group on Chronic Kidney Disease

. 2025 ; 63 (3) : 525-534. [pub] 20241126

Language English Country Germany

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc25009820

The 2024 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for chronic kidney disease (CKD) evaluation and management bring important updates, particularly for European laboratories. These guidelines emphasize the need for harmonization in CKD testing, promoting the use of regional equations. In Europe, the European Kidney Function Consortium (EKFC) equation is particularly suited for European populations, particularly compared to the CKD-EPI 2021 race-free equation. A significant focus is placed on the combined use of creatinine and cystatin C to estimate glomerular filtration rate (eGFRcr-cys), improving diagnostic accuracy. In situations where eGFR may be inaccurate or clinically insufficient, the guidelines encourage the use of measured GFR (mGFR) through exogenous markers like iohexol. These guidelines emphasize the need to standardize creatinine and cystatin C measurements, ensure traceability to international reference materials, and adopt harmonized reporting practices. The recommendations also highlight the importance of incorporating risk prediction models, such as the Kidney Failure Risk Equation (KFRE), into routine clinical practice to better tailor patient care. This article provides a European perspective on how these KDIGO updates should be implemented in clinical laboratories to enhance CKD diagnosis and management, ensuring consistency across the continent.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009820
003      
CZ-PrNML
005      
20250429135104.0
007      
ta
008      
250415s2025 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/cclm-2024-1082 $2 doi
035    __
$a (PubMed)39584585
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Cavalier, Etienne $u Department of Clinical Chemistry, University of Liège, CIRM, CHU de Liège, Liège, Belgium $1 https://orcid.org/0000000309472226
245    10
$a Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease / $c E. Cavalier, T. Zima, P. Datta, K. Makris, E. Schaeffner, M. Langlois, M. Plebani, P. Delanaye, EFLM Task Group on Chronic Kidney Disease
520    9_
$a The 2024 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for chronic kidney disease (CKD) evaluation and management bring important updates, particularly for European laboratories. These guidelines emphasize the need for harmonization in CKD testing, promoting the use of regional equations. In Europe, the European Kidney Function Consortium (EKFC) equation is particularly suited for European populations, particularly compared to the CKD-EPI 2021 race-free equation. A significant focus is placed on the combined use of creatinine and cystatin C to estimate glomerular filtration rate (eGFRcr-cys), improving diagnostic accuracy. In situations where eGFR may be inaccurate or clinically insufficient, the guidelines encourage the use of measured GFR (mGFR) through exogenous markers like iohexol. These guidelines emphasize the need to standardize creatinine and cystatin C measurements, ensure traceability to international reference materials, and adopt harmonized reporting practices. The recommendations also highlight the importance of incorporating risk prediction models, such as the Kidney Failure Risk Equation (KFRE), into routine clinical practice to better tailor patient care. This article provides a European perspective on how these KDIGO updates should be implemented in clinical laboratories to enhance CKD diagnosis and management, ensuring consistency across the continent.
650    _2
$a lidé $7 D006801
650    12
$a chronická renální insuficience $x diagnóza $x terapie $7 D051436
650    12
$a hodnoty glomerulární filtrace $7 D005919
650    12
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a klinické laboratoře $7 D000090464
650    _2
$a cystatin C $x krev $7 D055316
650    _2
$a kreatinin $x krev $7 D003404
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Zima, Tomáš $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Datta, Pradip $u Siemens Healthineers Diagnostics, Newark, DE, USA
700    1_
$a Makris, Konstantinos $u Clinical Biochemistry Department, KAT General Hospital, Kifissia, Athens, Greece $1 https://orcid.org/0000000278969028
700    1_
$a Schaeffner, Elke $u Division of Nephrology and Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany
700    1_
$a Langlois, Michel $u Department of Laboratory Medicine, AZ St. Jan Hospital, Bruges, Belgium
700    1_
$a Plebani, Mario $u Honorary Professor of Clinical Biochemistry and Clinical Molecular Biology, University of Padova, Padova, Italy $u Department of Pathology, University of Texas, Galveston, TX, USA $1 https://orcid.org/0000000202701711
700    1_
$a Delanaye, Pierre $u Department of Nephrology-Dialysis-Transplantation, University of Liège, CHU de Liège, Belgium $u Department of Nephrology-Dialysis-Apheresis, Hôpital Universitaire Carémeau, Nîmes, France $1 https://orcid.org/0000000214805761
710    2_
$a EFLM Task Group on Chronic Kidney Disease
773    0_
$w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 63, č. 3 (2025), s. 525-534
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39584585 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135100 $b ABA008
999    __
$a ok $b bmc $g 2311294 $s 1246901
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 63 $c 3 $d 525-534 $e 20241126 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Archiving options